Study identifier:NIS-CIT-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Regional Observatory on Metabolic Syndrome in Italy- LAZIO
Metabolic Syndrome
-
No
-
All
1574
Observational
18 Years - 75 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Primary care population | - |